These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7976642)

  • 1. Pharmacokinetic study of mannitol in subjects with increased ICP.
    Kobayashi T; Ichikawa T; Kondo R; Yoshiyama Y; Tomonaga F; Ohwada T
    Acta Neurochir Suppl (Wien); 1994; 60():538-40. PubMed ID: 7976642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic basis of mannitol administration in the treatment of raised ICP].
    Tanaka M; Yoshiyama Y; Kobayashi T; Tomonaga F; Kondo R; Takagi H; Ohwada T
    No Shinkei Geka; 1991 Jul; 19(7):619-24. PubMed ID: 1909772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of mannitol on intracranial pressure in relation to serum osmolality in a cat model of cerebral edema.
    Silver P; Nimkoff L; Siddiqi Z; Estrada R; Sagy M
    Intensive Care Med; 1996 May; 22(5):434-8. PubMed ID: 8796395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mannitol on increased intracranial pressure.
    McGraw CP; Howard G
    Neurosurgery; 1983 Sep; 13(3):269-71. PubMed ID: 6413884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intravenous fluid replacement on the response to mannitol in experimental cerebral edema: an analysis of intracranial pressure, serum osmolality, serum electrolytes, and brain water content.
    James HE
    Acta Neurochir Suppl; 2006; 96():125-9. PubMed ID: 16671439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannitol, intracranial pressure, and vasogenic edema.
    Hartwell RC; Sutton LN
    Neurosurgery; 1993 Mar; 32(3):444-50; discussion 450. PubMed ID: 8455770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon.
    Node Y; Nakazawa S
    Adv Neurol; 1990; 52():359-63. PubMed ID: 2118716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Furosemide and mannitol in the treatment of acute experimental intracranial hypertension.
    Wilkinson HA; Rosenfeld SR
    Neurosurgery; 1983 Apr; 12(4):405-10. PubMed ID: 6406929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7.2% NaCl/10% dextran 60 versus 20% mannitol for treatment of intracranial hypertension.
    Berger S; Schürer L; Härtl R; Deisböck T; Dautermann C; Murr R; Messmer K; Baethmann A
    Acta Neurochir Suppl (Wien); 1994; 60():494-8. PubMed ID: 7526628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short term volume effects of a hypertonic saline bolus during neurosurgery.
    Henschen S; Busse MW; Zisowsky S; Panning B; Piepenbrock S; Staffensky RH
    Neurochirurgia (Stuttg); 1991 Nov; 34(6):163-5. PubMed ID: 1775204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of post-traumatic intracranial hypertension by hypertonic/hyperoncotic saline/dextran and hypertonic mannitol.
    Berger S; Schürer L; Härtl R; Messmer K; Baethmann A
    Neurosurgery; 1995 Jul; 37(1):98-107; discussion 107-8. PubMed ID: 8587698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of indomethacin in brain-injured patients with cerebral perfusion pressure impairment: preliminary report.
    Biestro AA; Alberti RA; Soca AE; Cancela M; Puppo CB; Borovich B
    J Neurosurg; 1995 Oct; 83(4):627-30. PubMed ID: 7674011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study on reductions of intracranial pressure by therapeutic agents. I. The effects of mannitol through various methods of administration and the rebound phenomenon caused by the agent].
    Node Y
    Nihon Ika Daigaku Zasshi; 1982; 49(6):745-51. PubMed ID: 6820023
    [No Abstract]   [Full Text] [Related]  

  • 14. Osmotherapy for increased intracranial pressure: comparison between mannitol and glycerol.
    Biestro A; Alberti R; Galli R; Cancela M; Soca A; Panzardo H; Borovich B
    Acta Neurochir (Wien); 1997; 139(8):725-32; discussion 732-3. PubMed ID: 9309287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on intracranial pressure of furosemide combined with varying doses and administration rates of mannitol.
    Roberts PA; Pollay M; Engles C; Pendleton B; Reynolds E; Stevens FA
    J Neurosurg; 1987 Mar; 66(3):440-6. PubMed ID: 3102698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer-assisted analysis of intraventricular pressure after mannitol administration.
    Szewczykowski J; Sliwka S; Kunicki A; Korsak-Sliwka J; Dziduszko J; Dytko P; Augustyniak B
    J Neurosurg; 1975 Aug; 43(2):136-41. PubMed ID: 1185246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous mannitol on cat pial arteries and veins during normal and elevated intracranial pressure.
    Auer LM; Haselsberger K
    Neurosurgery; 1987 Aug; 21(2):142-6. PubMed ID: 3116450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodology for the control of intracranial pressure with hypertonic mannitol.
    James HE
    Acta Neurochir (Wien); 1980; 51(3-4):161-72. PubMed ID: 6768226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osmole gap in neurologic-neurosurgical intensive care unit: Its normal value, calculation, and relationship with mannitol serum concentrations.
    García-Morales EJ; Cariappa R; Parvin CA; Scott MG; Diringer MN
    Crit Care Med; 2004 Apr; 32(4):986-91. PubMed ID: 15071390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mannitol pharmacokinetics and serum osmolality in dogs and humans.
    Cloyd JC; Snyder BD; Cleeremans B; Bundlie SR; Blomquist CH; Lakatua DJ
    J Pharmacol Exp Ther; 1986 Feb; 236(2):301-6. PubMed ID: 3080582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.